Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded
- Contract number
- SPE2DR26F9P2Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,828
Award facts
- Contract value 100% obligated
- $18,828.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Ozempic 0.25–0.5 mg/dose pens in 3 mL vials, valued at $18,828.24. This competitively awarded, firm fixed-price delivery order is not set-aside and is scheduled for completion by November 21, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a broad range of medications, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contracting history demonstrates extensive capability in fulfilling diverse pharmaceutical requirements through competitively awarded contracts with the DLA Medical Supply Chain, encompassing specialty medications, brand-name and generic drugs, and specialized medical supplies across multiple therapeutic domains. The DLA Troop Support Medical contract under which this delivery order is issued represents a strategic approach to ensuring reliable pharmaceutical support for military personnel and veterans worldwide.
Quick answers
Who was awarded contract SPE2DR26F9P2Q?
SPE2DR26F9P2Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F9P2Q worth?
The government has obligated $18,828 on SPE2DR26F9P2Q.
Is contract SPE2DR26F9P2Q an order under another contract?
Yes. SPE2DR26F9P2Q is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9P2Q competed?
The extent of competition for SPE2DR26F9P2Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award